Glucocorticoid Receptor Blockade With Mifepristone in Patients With Mild Adrenal Hypercortisolism
NCT01990560 is a phase 4 interventional trial sponsored by Icahn School of Medicine at Mount Sinai. As of 21 Nov 2026, it is completed. It studies Mifepristone in Mild Hypercortisolism. The registry lists an enrollment of 8 participants at 1 site in 1 country. The registry lists a start date of 30 Nov 2013 and a primary completion date of 30 Sept 2016.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT01990560 |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional trial |
| Lead sponsor | Icahn School of Medicine at Mount Sinai |
| Enrollment | 8 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Mild Hypercortisolism |
| Drugs | Mifepristone |
| Start | 30 Nov 2013 |
| Primary completion | 30 Sept 2016 |
| Study completion | 30 Sept 2016 |
| Last update posted | 2 Mar 2018 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Alice C Levine, MD
Icahn School of Medicine at Mount Sinai
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Icahn School of Medicine at Mount Sinai
New York
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Questions about NCT01990560
Each answer restates registry values shown on this page.
What is NCT01990560?
NCT01990560 is a phase 4 interventional trial sponsored by Icahn School of Medicine at Mount Sinai. It studies Mifepristone in Mild Hypercortisolism.
Who leads NCT01990560?
The registry names Alice C Levine, MD (principal investigator, Icahn School of Medicine at Mount Sinai) as the overall official.
Where does NCT01990560 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
Which drugs does NCT01990560 study?
The registered drug and biological interventions are Mifepristone.
When did NCT01990560 end?
The registry lists a primary completion date of 30 Sept 2016 and a study completion date of 30 Sept 2016. The sponsor last updated the record on 2 Mar 2018.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.